Neurology News

The FDA has approved an adeno-associated virus vector-based gene therapy to treat both adult and pediatric patients with aromatic L-amino acid decarboxylase deficiency.

Why not just invest in one stock and let it ride? That works well if you bet the farm on Apple in 2010 and watched your fortune explode 30 time during the last 14 years.

Treatment with oral blarcamesine for older adults with Alzheimer’s disease led to significant slowing of clinical decline compared with placebo at 48 weeks, according to new research presented at CTAD.

Treatment with IV nipocalimab was safe and led to significant reductions in disease expression at 24 weeks in adolescents with generalized myasthenia gravis, according to data presented at AANEM.

An oral therapeutic significantly reduced the number of tumors in adults with neurofibromatosis type 1 who have symptomatic, inoperable plexiform neurofibromas, according to topline results from a phase 3 study.

Chimeric antigen receptor T-cell therapy can reduce tumor burden and improve neurologic function for patients with certain brain and spinal cord cancers, a first-in-human clinical trial showed.

In families with genetic epilepsy and febrile seizures, relatives who showed higher polygenic risk scores were more likely to have an epilepsy diagnosis along with a more severe phenotype, according to new research.

Individuals with a predelivery history of concussion appeared to be at increased risk for severe maternal mental illness, highlighting the importance of screening and supportive care for this high-risk group, according to researchers.

Features of memory retention in cells may result from embedded signaling dynamics in the body, with information stored best in spaced bursts rather than in a single, massed event, according to research from Nature Communications.

Adults aged 50 years and older, particularly women, who experienced obstructive sleep apnea appeared to be at higher risk for dementia, according to a new study published in SLEEP Advances.